Cartesian Therapeutics (RNAC) Institutional Ownership $15.92 -0.02 (-0.13%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)CurrentInstitutional OwnershipPercentage86.95%Number ofInstitutional Buyers(last 12 months)35TotalInstitutional Inflows(last 12 months)$373.77MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$77.50M Get RNAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RNAC Institutional Buying and Selling by Quarter Remove Ads Cartesian Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Two Sigma Investments LP11,812$212K0.0%-8.5%0.046% 2/17/2025 MPM Bioimpact LLC721,139$12.92M1.8%+14.6%2.837% 2/17/2025 Nuveen Asset Management LLC72,099$1.29M0.0%+197.8%0.284% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,786$104K0.0%+44.8%0.023% 2/17/2025 Citadel Advisors LLC315,000$5.64M0.0%-16.2%1.239% 2/17/2025 Bank of America Corp DE11,690$209K0.0%+54.4%0.046% 2/17/2025 683 Capital Management LLC125,000$2.24M0.1%+65.7%0.492% 2/14/2025 Northern Trust Corp95,030$1.70M0.0%+50.6%0.374% 2/14/2025 Virtus ETF Advisers LLC3,533$63K0.0%N/A0.014% 2/14/2025 MetLife Investment Management LLC6,667$119K0.0%N/A0.026% Get the Latest News and Ratings for RNAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025 Barclays PLC19,099$342K0.0%+64.5%0.075% 2/13/2025 Renaissance Technologies LLC13,800$247K0.0%N/A0.054% 2/13/2025 Wells Fargo & Company MN4,847$87K0.0%+112.7%0.019% 2/12/2025 Geode Capital Management LLC221,257$3.96M0.0%+63.0%0.870% 2/12/2025 JPMorgan Chase & Co.274,740$4.92M0.0%-11.1%1.081% 2/11/2025 Corebridge Financial Inc.5,122$92K0.0%+32.6%0.020% 2/10/2025 Erste Asset Management GmbH173,566$3.26M0.0%-93.6%0.683% 2/6/2025 Charles Schwab Investment Management Inc.26,803$480K0.0%+40.7%0.105% 2/4/2025 Bank of New York Mellon Corp19,407$348K0.0%+28.5%0.076% 1/31/2025 New York State Common Retirement Fund3,902$70K0.0%-23.5%0.015% 1/30/2025 Rhumbline Advisers10,201$183K0.0%+10.0%0.040% 1/27/2025 Mirae Asset Global Investments Co. Ltd.4,562$82K0.0%+22.8%0.018% 1/24/2025 China Universal Asset Management Co. Ltd.5,389$97K0.0%N/A0.021% 12/26/2024 JPMorgan Chase & Co.309,018$4.98M0.0%+0.9%1.216% 11/19/2024 Barclays PLC11,611$188K0.0%+208.6%0.046% 11/16/2024 Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534% 11/15/2024 Barclays PLC11,611$188K0.0%+208.6%0.046% 11/15/2024 State Street Corp157,495$2.54M0.0%+2.5%0.620% 11/15/2024 Ikarian Capital LLC52,193$841K0.1%-78.5%0.205% 11/13/2024 Great Point Partners LLC200,000$3.22M0.9%N/A0.787% 11/13/2024 BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006% 11/13/2024 FMR LLC2,851,830$45.97M0.0%+458.3%11.219% 10/23/2024 Lake Street Advisors Group LLC15,822$255K0.0%-50.0%0.074% 9/16/2024 Point72 DIFC Ltd1,725$47K0.0%N/A0.008% 9/16/2024 Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061% 9/16/2024 Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009% 8/27/2024 Logos Global Management LP90,000$2.43M0.2%N/A0.506% 8/15/2024 Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009% 8/14/2024 Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061% 8/14/2024 Point72 DIFC Ltd1,725$47K0.0%N/A0.008% New “Trump” currency proposed in DC (Ad)According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. When you see what could happen – I think you’ll be excited.8/14/2024 Marshall Wace LLP30,038$811K0.0%N/A0.140% 8/14/2024 Logos Global Management LP90,000$2.43M0.2%N/A0.421% 8/9/2024 Renaissance Technologies LLC17,052$461K0.0%-96.9%0.096% 8/6/2024 Lake Street Advisors Group LLC31,644$855K0.0%N/A0.178% 8/1/2024 Rhumbline Advisers8,487$229K0.0%-93.5%0.048% 7/26/2024 Bank of New York Mellon Corp19,916$538K0.0%-93.7%0.112% 7/22/2024 Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010% 5/17/2024 Artal Group S.A.9,136,635$5.94M0.2%N/A171.098% 5/14/2024 American International Group Inc.56,202$37K0.0%N/A1.052% 5/10/2024 Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172% 5/7/2024 SG Americas Securities LLC47,134$31K0.0%N/A0.883% 5/3/2024Delphi Financial Group Inc.660,852$430K0.3%N/A12.261% 5/1/2024 BNP Paribas Financial Markets59,125$38K0.0%N/A1.097% 4/23/2024 Hall Laurie J Trustee52,775$34K0.0%N/A0.979% (Data available from 1/1/2016 forward)Remove Ads RNAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RNAC shares? During the previous two years, 40 institutional investors and hedge funds held shares of Cartesian Therapeutics. The most heavily invested institutionals were FMR LLC ($45.97M), MPM Bioimpact LLC ($12.92M), Artal Group S.A. ($5.94M), Citadel Advisors LLC ($5.64M), JPMorgan Chase & Co. ($4.92M), Vanguard Group Inc. ($4.11M), and Geode Capital Management LLC ($3.96M).Learn more on RNAC's institutional investors. What percentage of Cartesian Therapeutics stock is owned by institutional investors? 86.95% of Cartesian Therapeutics stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings. Which institutional investors have been buying Cartesian Therapeutics stock? Of the 35 institutional investors that purchased Cartesian Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Artal Group S.A. ($9.14M), Vanguard Group Inc. ($6.32M), FMR LLC ($2.34M), Delphi Financial Group Inc. ($660.85K), Great Point Partners LLC ($200K), Logos Global Management LP ($180K), and MPM Bioimpact LLC ($91.72K). How much institutional buying is happening at Cartesian Therapeutics? Institutional investors have bought a total of 19,536,644 shares in the last 24 months. This purchase volume represents approximately $373.77M in transactions. Which Cartesian Therapeutics major shareholders have been selling company stock? Of the 11 institutional investors that sold Cartesian Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Erste Asset Management GmbH ($2.53M), Renaissance Technologies LLC ($536.55K), Bank of New York Mellon Corp ($297.41K), Ikarian Capital LLC ($190.18K), Rhumbline Advisers ($121.40K), Citadel Advisors LLC ($60.77K), and Hall Laurie J Trustee ($51.02K). How much institutional selling is happening at Cartesian Therapeutics? Institutional investors have sold a total of 3,836,709 shares in the last 24 months. This volume of shares sold represents approximately $77.50M in transactions. Related Companies ANIP Institutional Ownership DYN Institutional Ownership INDV Institutional Ownership AMPH Institutional Ownership ARDX Institutional Ownership EVO Institutional Ownership ETNB Institutional Ownership OCUL Institutional Ownership GPCR Institutional Ownership IOVA Institutional Ownership This page (NASDAQ:RNAC) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RNAC Stock Free RNAC Stock Alerts